PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in ACORN CAPITAL ADVISORS, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which ACORN CAPITAL ADVISORS, LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
11.14% (2025 Q3)
Avg. % of fund
8.67%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 4,131,299 — 0% 8.33% $24.6M $5.95
2025 Q3 UNCHANGED 4,131,299 — 0% 11.14% $21.9M $5.31
2025 Q2 ADDED 4,131,299 +191,247 +4.9% 9.27% $14.17B $3.43
2025 Q1 ADDED 3,940,052 +1,489,341 +60.8% 8.12% $11.7M $2.96
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to ACORN CAPITAL ADVISORS, LLC Holdings